Europe - Ireland

Pinsent Masons LLP

We only have limited information for this firm. Consider the following firms which have provided more information:

Pinsent Masons LLP’s intellectual property team stands out for its strong patent litigation practice, assisting major Irish clients with proceedings arising from patent revocation and infringement, with specific expertise in the pharmaceuticals sector. The team also provides comprehensive advice on the registration and enforcement of trade marks and the exploitation of IP through licensing and franchising. Practice head Karen Gallagher specialises in contentious IP matters and regularly represents clients before the Irish courts. The team was further strengthened by the arrival of Maureen Daly from Beauchamps LLP in November 2023.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The Pinsent Masons Ireland team is highly knowledgeable and experienced in intellectual property. There is impressive attention to detail and dedication to ongoing education and learning about the most current developments in the area, domestically and internationally, through their global and tightly-knit network of legal experts. They have an insight into the needs of their clients across many jurisdictions and a coherent and skilled approach to meeting them.’
  • ‘Karen Gallagher is highly knowledgeable and experienced in patent litigation. She brings an innovative and energetic perspective to patent disputes and is extremely hard-working. She is very focussed on the needs of clients and solutions to meet them.’

Abbreviated data is displayed for this firm.

Key clients

  • Teva Pharmaceutical Industries Limited
  • Norton (Waterford) Limited

Abbreviated data is displayed for this firm.

Work highlights

  • Represented Teva in relation to two sets of patent and SPC revocation proceedings issued against Bristol-Myers Squibb Ireland Unlimited Company and Pfizer Inc.
  • Represented Accord in the defence of patent infringement proceedings brought by Novartis in relation to two European patents.

Abbreviated data is displayed for this firm.